Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128576) titled 'Romiplostim N01 for the Treatment of Thrombocytopenia Associated With Radiotherapy-Combined Treatment Regimens in Patients With Solid Tumors' on Aug. 13.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Zhujiang Hospital
Condition:
Thrombocytopenia
Thrombocytopenia Associated With Radiotherapy-combined Treatment Regimens
Solid Tumors
Intervention:
Drug: Romiplostim N01
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: August 15, 2025
Target Sample Size: ...